Intellia Therapeutics will find it challenging to survive now that its CRISPR gene-editing treatment has been tied to severe, ...

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...

Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, a practice that has ...

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

Some conservation groups are calling for an effective ban on genetic modification, but others say these technologies are crucial for preserving biodiversity ...

The invention has made it onto TIME’s 2025 Best Inventions list, in the food and drink category, and would be the first new ...

As alternatives to intravascular lithotripsy, cutting balloon angioplasty and super-high-pressure non-compliant balloons were noninferior in the Short-CUT and VICTORY trials, as highlighted by the ...

Reproductive biologists at Nanjing University tried to see whether a male mouse's mastery of treadmill running could somehow ...

A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

The company said dosing in its Phase III MAGNITUDE-1 and MAGNITUDE-2 studies for transthyretin amyloidosis (ATTR) had been voluntarily paused after a patient in the cardiomyopathy trial was ...

Earlier, Adam held leadership roles at CRISPR Therapeutics and Biogen ... expectations regarding the therapeutic benefits, ...